Stand-Off: Vertex Refuses NICE Data on CF Drug Symkevi, HTA Body Awaits Next Move

 
• By Sten Stovall

Vertex says it will not file data on its cystic fibrosis drug Symkevi (tezacaftor/ivacaftor) until the UK's NICE changes the way it assesses drugs.

Hombre
Who will make the next move in the Vertex/NICE standoff? • Source: Shutterstock

More from Approvals

More from Product Reviews